Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

With fewer Part D plans and a $2,000 out-of-pocket cap, beneficiaries must rethink their Medicare drug coverage for 2025.

Changes to Medicare in 2025 include a cap on out-of-pocket prescription drug costs, changes to mental health care services, ...

The U.S. pharmaceutical industry is pushing to revamp the new law that allows Medicare to negotiate prices for its costliest ...

It's common for Medicare Advantage plans to require prior authorizations for tests or procedures that are out of the ordinary ...

Robert Powell: Are you about to enroll in Medicare and trying to decide whether to sign up for a Medicare Advantage plan or ...

Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

A record-low number of Medicare Part D plans could cause greater Medicare Advantage enrollment, which may not be a good thing ...

Millions of Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare and ...

The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...

We’re continuing our coverage about health care options for seniors. MTPR health care reporter Aaron Bolton is back to talk ...